Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. SNOW
10. USO

Go back to Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
(NASDAQ: TRVI) Delayed: 17.05 +0.48 (2.90%)
Previous Close $16.57    52 Week High $ 
Open $16.57    52 Week Low $ 
Day High $17.12    P/E N/A 
Day Low $16.22    EPS $ 
Volume 1,350,083